innovations in Genetic Engineering / Molecular Biology | Innoget

innovations in Genetic Engineering / Molecular Biology | Innoget

Technology Categories

By Type

Unitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV

New method for the diagnosis of diseases caused by helminths Cystic Echinococcosis, also known as hydatid disease (Hydatidosis), is a parasitic disease caused by the tapeworms of genus Echinococcus. Hydatidosis is globally distributed and found in every continent except Antarctica. Endemic areas are parts of Argentina, Peru, East Africa, Central Asia and China. The infection to humans occur through the ingestion of parasite eggs in contaminated water, food, soil or through direct contact with animal hosts such as dogs and sheep. Human infection with E. granulosus leads to the development of one or more hydatid cysts located most often in the liver and lungs, and less frequently in the bones, kidneys, spleen, muscles, central nervous system and eyes. The asymptomatic incubation period of the disease can last many years until hydatid cysts grow to an extent that triggers clinical signs. The diagnosis is done through ultrasonography imaging, which is usually complemented or validated by computed tomography and/or magnetic resonance imaging scans. Cysts can be incidentally discovered by radiography. Specific antibodies are detected by different serological tests and can support the diagnosis. Biopsies and ultrasound-guided punctures may also be performed for differential diagnosis of cysts from tumours and abscesses. In this invention, a new system for non-invasive, early, fast and easy to use diagnosis test for Hydatidosis from exhaled breath analysis has been developed.

New method for the diagnosis of diseases caused by helminths

Maria João Cardoso posted this:
Science and Technology Manager at UATEC - Unidade de Transferência de Tecnologia

Magnetic nanoparticles for selective enrichment of proteins in complex mixtures New method for preparing ion chelating magnetic nanoparticles, which allow selective protein enrichment, namely metalloproteases (MMPs) and His-tagged proteins, from complex mixtures.

Magnetic nanoparticles for selective enrichment of proteins in complex mixtures

Maria João Cardoso posted this:
Science and Technology Manager at UATEC - Unidade de Transferência de Tecnologia

Biopolymer based micro- and nano-particles for industrial and environmental applications Method for preparing hybrid materials based on biopolymer and silica, in the form of spherical particles with uniform size and smaller than 1 micrometer (µm), for several applications in environmental and industrial areas.

Biopolymer based micro- and nano-particles for industrial and environmental applications

Ukrainian Laboratories posted this:

New Original Squaraine Dye for protein detection Ukrainian Laboratories represents the original new squaraine dye for the protein detection. The dye is already synthesized and ready to use for biomedical application. The dye has a significant increase in the fluorescence intensity in the presence of protein (123 times) and does not change its intensity in the presence of nucleic acids.

New Original Squaraine Dye for protein detection

Universidad de Alcalá-OTRI posted this:

Endothelial microvesicles with microbicidal effect for the preparation of a medicament or for a direct use The research group "Cell damage associated with senescence" of the University of Alcalá presents the microbicidal capacity of endothelial microvesicles. These vesicles destroy the main pathogens involved in sepsis and even strains derived from them resistant to multiple antibiotics. They have also been shown to be effective against the biofilms that form these microorganisms. The group seeks to reach licensing agreements, cooperation or commercial agreements with technical assistance, with pharmaceutical companies interested in the design of new medicines.

Endothelial microvesicles with microbicidal effect for the preparation of a medicament or for a direct use

Núria Brunet i Garcia posted this:
Licensing Manager at Universitat de Lleida

New therapeutic candidate for Spinal Muscular Atrophy We are looking for a licensing agreement with a company with expertise in the field of neurosciences. More particularly, we are willing to find a company involved in the development of therapeutic solutions for the rare disease Spinal Muscular Atrophy (SMA).

Eva Gabaldon posted this:
Licensing Manager at Spanish National Research Council

Extracellular matrix for increase the synthesis and/or deposit of collagen CSIC has developed an extracellular matrix with increased synthesis and/or deposit of collagen that is capable of regulating the differentiation of mesenchymal stem cells. Industrial partners from the biotechnological industry are being sought to collaborate through a patent licence agreement.

Jordi Reverter posted this:
Licensing Manager at Institut Català de Nanociència i Nanotecnologia

New Nanoporous Graphene material A bottom up unique method build the holy graphene from molecular blocks. The molecular blocks used define the size and shape of the pores, which are identical with atomic precision. We can also control the chemical functionalization of the material. This material has semiconducting properties with a bandgap similar to Si, opening new applications for graphene-based materials. This new material can be used for sieving, sensing, (opto)electronics or its combinations.

New Nanoporous Graphene material

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

Sequencing Platform - Luxembourg Centre for Systems Biomedicine The LCSB Sequencing Platform provides sequencing DNA or RNA samples with very high accuracy, efﬁciency and depth with tunable read lengths and output options according to research needs.

Sequencing Platform - Luxembourg Centre for Systems Biomedicine

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

Metabolomics Platform - Luxembourg Centre for Systems Biomedicine The LCSB Metabolomics Platform is specialized in developing and applying mass spectrometry-based comprehensive analysis methods of small molecules in complex biological matrices. Our Platform works with national and international partners from academia and industry to help them reach their research goals. To address the needs in this fast-changing field, our Platform continuously develops new analytical and tailor-made methods in response to upcoming biological and biomedical questions.

Metabolomics Platform - Luxembourg Centre for Systems Biomedicine

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

Bioimaging Platform - Luxembourg Centre for Systems Biomedicine The LCSB Bioimaging Platform (bip) provides access to and support for a broad palette of advanced microscopy and flow cytometry instruments, enabling researchers to perform studies from the tissue level and down to sub-cellular scales.

Bioimaging Platform - Luxembourg Centre for Systems Biomedicine

Lidia Aguilera posted this:
Technology Transfer Officer at University of Luxembourg

AQUATIC PLATFORM - Luxembourg Centre for Systems Biomedicine The LCSB Aquatic Platform is centred around the use of zebrafish (Danio rerio), a vertebrate model with high genetic and physiologic similarity to humans. This versatile, reliable model organism is widely used for the in vivo study of developmental biology, gene function, drug discovery and pathophysiological aspects of various human diseases such as epilepsy, rare diseases, neurodegenerative disorders, among others.

AQUATIC PLATFORM - Luxembourg Centre for Systems Biomedicine

NANOMYP posted this:

PolymP®-Active (Zn): Polymeric particles to reduce dentin hypersensitivity PolymP®-Active (Zn) is a breakthrough material that we have just patented for potentially treating dentin hypersensitivity. This new material (based on biocompatible polymeric particles) shows, among many others, the following key benefits: -Induces natural remineralization in few hours enhancing the precipitation of natural minerals that are not dissolved by saliva. -Low Mohs hardness: Do not result in dentin or enamel abrasion. -Fully occludes dentinal tubules enhancing surface nanohardness. -Possess antibacterial activity. -Inhibits dentin metalloproteinases, preventing the accelerated destruction of dentin. From a regulatory standpoint, the product could be developed as a cosmetic.

UNIVERSIDAD DE BURGOS posted this:

Method of preparation and use of derivatives of perylene-diimide (PDI) in different applications such as bioimaging or biomarkers.The present invention provides a methodology for the synthesis of derivatives of perylene-diimide (PDI, for which there was no obtention process, and its use in different applications such as bioimaging or biomarkers.

Method of preparation and use of derivatives of perylene-diimide (PDI) in different applications such as bioimaging or biomarkers.

Yissum - Research Development Company of the Hebrew University posted this:

A novel target for the treatment of genetic diseases caused by nonsense mutations A novel target for the treatment of genetic diseases caused by nonsense mutations Project ID : 6-2018-4579

1
2
3
4
5